An artificial intelligence algorithm can determine non-invasively, with about 70 percent accuracy, if an in vitro fertilized embryo has a normal or abnormal number of chromosomes, according to a new study from researchers at Weill Cornell...
Read more
Weill Cornell Medicine investigators have identified definitive biological links between African ancestry and disease processes that affect an aggressive cancer type called triple-negative breast cancer (TNBC). Their analysis of TNBC tumors from...
Read more
Researchers Identify the Target of Immune Attacks on Liver Cells in Metabolic Disorders When fat accumulates in the liver, the immune system may assault the organ. A new study from Weill Cornell Medicine researchers identifies the molecule that...
Read more
Novel Technique Provides Insights into Lung Pathology in COVID-19 Investigators at Weill Cornell Medicine and NewYork-Presbyterian have used advanced technology and analytics to map, at single-cell resolution, the cellular landscape of diseased...
Read more
Immunotherapy unleashes the power of the immune system to fight cancer. However, for some patients, immunotherapy doesn’t work, and new research may help explain why. When immune cells called T lymphocytes infiltrate malignant tumors, the genetic...
Read more
Novel Technique Provides Insights into Lung Pathology in COVID-19 Investigators at Weill Cornell Medicine and NewYork-Presbyterian have used advanced technology and analytics to map, at single-cell resolution, the cellular landscape of...
Read more
Scientists Find a New Way to Reverse Immune Suppression in Tumors Malignant tumors can enhance their ability to survive and spread by suppressing antitumor immune cells in their vicinity, but a study led by researchers at Weill Cornell Medicine...
Read more
Ready to Launch: Weill Cornell Has an Ambitious New Plan to Change Medicine Medicine is at a watershed moment: decades of technological advances have revealed unprecedented insights into human biology and how various physiological, genetic...
Read more
It’s an Absolute Miracle: Battling a Deadly Blood Cancer, a New Jersey Woman Gets a Second Chance — Thanks to Precision Medicine SEPTEMBER 7, 2021 Personalized Care: Dr. Gail Roboz (above right), examines patient Cheryl Bonder this spring as part...
Read more
New Treatment Option for Advanced Urothelial Cancer Patients Shows Promise in a Phase 2 Clinical Trial A new treatment for advanced urothelial cancer was effective with tolerable side effects in an international, multi-center phase 2...
Read more
Phase 2 Trial Shows Cell Therapy May Prevent Infections in Leukemia Patients Treatment with a ready-made preparation of human immune cells helps prevent infections in people whose immune systems are temporarily weakened by leukemia treatment...
Read more
Two gene variants found in African American women may explain why they are more likely to be diagnosed with triple negative breast cancer (TNBC) than white women of European ancestry, according to Weill Cornell Medicine and NewYork-Presbyterian...
Read more